|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Molecular Genetics |
Department of Laboratory Medicine and Pathology and Tumor Biology Program, Mayo Clinic and Foundation, Rochester, MN 55905
2 Address correspondence and reprint requests to C. David James, Mayo Clinic, 200 First St., S.W., Hilton Bldg. Rm. 820-D, Rochester, MN 55905.
Abstract
We have developed a polymerase chain reaction (PCR)-based strategy for the synthesis and analysis of rearranged epidermal growth factor receptor (EGFR) fragments associated with the vIII mutant receptor expressed in glioblastomas with EGFR amplification. The sequencing of aberrant tumor fragments showed that intragenic deletion rearrangements consistently involve an approximately 600-bp region in intron 7 of EGFR and several rearrangement sites interspersed throughout the large (>100 kb) first intron of this gene. Examination of the intron 7 breakpoint region revealed an Alu repeat element, and all intron 7 rearrangement sites were located within or downstream of this repeat sequence. Analysis of intron 1 for similar sequences resulted in the identification of 11 sites containing >80% homology with parts of the Alu element in intron 7. Reverse transcriptase-PCR and/or Western analysis of the tumors showed the presence of EGFRvIII cDNAs and/or proteins, respectively, in all cases for which a rearranged genomic fragment was generated by long-range PCR. Collectively, these data suggest that EGFR rearrangements, associated with the synthesis of the most common EGFR mutant, are mediated by a specific sequence element.
References
Bigner, S.H., Humphrey, P.A., Wong, A.J., Vogelstein, B., Mark, J.,
Friedman, H.S., and Bigner, D.D. (1990) Characterization of the
epidermal growth factor receptor in human glioma cell lines and xenografts.
Cancer Res. 50,8017
-8022.
Callaghan, T., Antczak, M., Flickinger, T., Raines, M., Myers, M., and Kung, H.J. (1993) A complete description of the EGF-receptor exon structure: implication in oncogenic activation and domain evolution. Oncogene 8,2939 -2948.[Web of Science][Medline]
Deininger, P.L., and Batzer, M.A. (1999) Alu repeats and human disease. Mol. Genet. Metab. 67,183 -193.[CrossRef][Web of Science][Medline]
Ekstrand, A.J., Sugawa, N., James, C.D., and Collins, V.P.
(1992) Amplified and rearranged epidermal growth factor receptor
genes in human glioblastomas reveal deletions of sequences encoding portions
of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci.
U.S.A. 89,4309
-4313.
Feldkamp, M.M., Lau, N., Rak, J., Kerbel, R.S., and Guha, A. (1999) Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras. Int. J. Cancer 81,118 -124.[CrossRef][Web of Science][Medline]
Foord, O.S., and Rose, E.A. (1994) Long-distance PCR. PCR Methods Appl. 3,S149 -S161.[Web of Science][Medline]
Frederick, L., Wang, X.-Y., Eley, G., and James, C.D.
(2000) Diversity and frequency of epidermal growth factor
receptor mutations in human glioblastomas. Cancer Res.
60,1383
-1387.
Goike, H.M., Asplund, A.C., Pettersson, E.H., Liu L., Sanoudou, D., and Collins, V.P. (1999) Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft. J. Neuropath. Exp. Neurol. 58,697 -701.[Web of Science][Medline]
Haley, J., Whittle, N., Bennet, P., Kinchington, D., Ullrich, A., and Waterfield, M. (1987) The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncogene Res. 1, 375-396.[Web of Science][Medline]
Holland, E.C., Hively, W.P., DePinho, R.A., and Varmus, H.E.
(1998) A constitutively active epidermal growth factor receptor
cooperates with disruption of G1 cell-cycle arrest pathways to induce
glioma-like lesions in mice. Genes Dev.
12,3675
-3685.
Humphrey, P.A., Wong, A.J., Vogelstein, B., Friedman, H.S., Werner,
M.H., Bigner, D.D., and Bigner, S.H. (1988) Amplification and
expression of the epidermal growth factor receptor gene in human glioma
xenografts. Cancer Res.
48,2231
-2238.
Humphrey, P.A., Wong, A.J., Vogelstein, B., Zalutsky, M.R., Fuller,
G.N., Archer, G.E., Friedman, H.S., Kwatra, M.M., Bigner, S.H., and Bigner,
D.D. (1990) Anti-synthetic peptide antibody reacting at the
fusion junction of deletion-mutant epidermal growth factor receptors in human
glioblastoma. Proc. Natl. Acad. Sci. U.S.A.
87,4207
-4211.
James, C.D., Carlbom, E., Dumanski, J.P., Hansen, M., Nordenskjold,
M., Collins V.P., and Cavenee, W.K. (1988) Clonal genomic
alterations in glioma malignancy stages. Cancer Res.
48,5546
-5551.
Libermann, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M.D., Ullrich, A., and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313,144 -147.[CrossRef][Medline]
Malden, L.T., Novak, U., Kaye, A.H., and Burgess, A.W.
(1988) Selective amplification of the cytoplasmic domain of the
epidermal growth factor receptor gene in glioblastoma multiforme.
Cancer Res. 48,2711
-2714.
Moscatello, D.K., Holgado-Madruga, M., Emlet, D.R., Montgomery,
R.B., and Wong, A.J. (1998) Constitutive activation of
phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth
factor receptor. J. Biol. Chem.
273,200
-206.
Nagane, M., Levitzki, A., Gazit, A., Cavenee, W.K., and Huang, H.J.
(1998) Drug resistance of human glioblastoma cells conferred by a
tumor-specific mutant epidermal growth factor receptor through modulation of
Bcl-XL and caspase-3-like proteases. Proc. Natl. Acad. Sci.
U.S.A. 95,5724
-5729.
Reiter, J.L., Eley G., Cora, E.M., Baron, A.T., James, C.D., and Maihle, N.J. (2000) Complete human EGFR gene structure and a novel 3 kb alternative transcript encoding a truncated 110 kDa form of the receptor. Proc. Am. Assoc. Cancer Res. 41, 5006.
Strohman, R.C. (1999) Five stages of the Human Genome Project. Nat. Biotechnol. 17, 112.[CrossRef][Web of Science][Medline]
Sugawa, N., Ekstrand, A.J., James, C.D., and Collins, V.P.
(1990) Identical splicing of aberrant epidermal growth factor
receptor transcripts from amplified rearranged genes in human glioblastomas.
Proc. Natl. Acad. Sci. U.S.A.
87,8602
-8606.
Wong, A.J., Ruppert, J.M., Bigner, S.H., Grzeschik, C.H., Humphrey,
P.A., Bigner, D.S., and Vogelstein, B. (1992) Structural
alterations of the epidermal growth factor receptor gene in human gliomas.
Proc. Natl. Acad. Sci. U.S.A.
89,2965
-2969.
Yamazaki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T.,
Taniguchi, S., and Shibuya, M. (1988) Amplification of the
structurally and functionally altered epidermal growth factor receptor gene
(c-erbB) in human brain tumors. Mol. Cell. Biol.
8,1816
-1820.
Yamazaki, H., Ohba, Y., Tamaoki N., and Shibuya M. (1990) A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res. 81,773 -779.[CrossRef][Web of Science][Medline]
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  P. H. Huang, A. M. Xu, and F. M. White Oncogenic EGFR Signaling Networks in Glioma Sci. Signal., September 8, 2009; 2(87): re6 - re6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Gazdar and J. D. Minna Deregulated EGFR Signaling during Lung Cancer Progression: Mutations, Amplicons, and Autocrine Loops Cancer Prevention Research, August 1, 2008; 1(3): 156 - 160. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. French, J. Peeters, S. Horsman, E. Duijm, I. Siccama, M. J. van den Bent, T. M. Luider, J. M. Kros, P. van der Spek, and P. A. Sillevis Smitt Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays Cancer Res., June 15, 2007; 67(12): 5635 - 5642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-K. Wong, Y. T.M. Tsang, Y.-M. Chang, J. Su, A. M. Di Francesco, D. Meco, R. Riccardi, L. Perlaky, R. C. Dauser, A. Adesina, et al. Genome-Wide Allelic Imbalance Analysis of Pediatric Gliomas by Single Nucleotide Polymorphic Allele Array Cancer Res., December 1, 2006; 66(23): 11172 - 11178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ji, X. Zhao, Y. Yuza, T. Shimamura, D. Li, A. Protopopov, B. L. Jung, K. McNamara, H. Xia, K. A. Glatt, et al. Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors PNAS, May 16, 2006; 103(20): 7817 - 7822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Choe, J. K. Park, L. Jouben-Steele, T. J. Kremen, L. M. Liau, H. V. Vinters, T. F. Cloughesy, and P. S. Mischel Active Matrix Metalloproteinase 9 Expression Is Associated with Primary Glioblastoma Subtype Clin. Cancer Res., September 1, 2002; 8(9): 2894 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Eley, J. L. Reiter, A. Pandita, S. Park, R. B. Jenkins, N. J. Maihle, and C. D. James A chromosomal region 7p11.2 transcript map: Its development and application to the study of EGFR amplicons in glioblastoma Neuro-oncol, April 1, 2002; 4(2): 86 - 94. [Abstract] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
